[HTML][HTML] In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom …

M Maes, WLD Tedesco Junior, MAB Lozovoy… - Molecular …, 2022 - nature.com
Abstract In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich
repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in …

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a …

M Maes, WLD Tedesco Junior, MAB Lozovoy… - 2023 - dro.deakin.edu.au
In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich repeat and
pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in response to …

[PDF][PDF] In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom …

M Maes, WLDT Junior, MAB Lozovoy, MTE Mori… - 2022 - researchgate.net
Although the majority of Corona virus disease (COVID-19) patients have mild clinical
manifestations, some patients may develop acute respiratory distress or even severe acute …

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a …

M Maes, WL del Tedesco Junior, MAB Lozovoy… - 2022 - cabidigitallibrary.org
Abstract In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich
repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in …

[HTML][HTML] In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom …

M Maes, WL Del Tedesco Junior, MAB Lozovoy… - 2021 - europepmc.org
Background In COVID-19, the NLRP3 inflammasome is activated in response to SARS-CoV-
2 infection. Acute infections are accompanied by a sickness symptom complex (SSC) which …

[HTML][HTML] In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom …

M Maes, WLDT Junior, MAB Lozovoy… - Molecular …, 2022 - ncbi.nlm.nih.gov
Abstract In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich
repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in …

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a …

M Maes, WLDT Junior, MAB Lozovoy… - Molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich repeat and
pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in response to …

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a …

M Maes, WL Del Tedesco Junior, MAB Lozovoy… - medRxiv, 2021 - medrxiv.org
Abstract Background In COVID-19, the NLRP3 inflammasome is activated in response to
SARS-CoV-2 infection. Acute infections are accompanied by a sickness symptom complex …

[PDF][PDF] In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom …

M Maes, WLDT Junior, MAB Lozovoy, MTE Mori… - 2022 - researchgate.net
Although the majority of Corona virus disease (COVID-19) patients have mild clinical
manifestations, some patients may develop acute respiratory distress or even severe acute …

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a …

M Maes, WLD Tedesco Junior, MAB Lozovoy… - 2023 - dro.deakin.edu.au
In coronavirus disease (COVID-19), the nucleotide-binding domain, leucine-rich repeat and
pyrin domain-containing protein 3 (NLRP3) inflammasome is activated in response to …